MORGAN STANLEY - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 26 filers reported holding PSYCHEMEDICS CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q3 2023$17,865
-76.3%
4,500
-72.8%
0.00%
Q2 2023$75,432
-11.7%
16,542
+1.7%
0.00%
Q1 2023$85,418
+46.9%
16,270
+37.2%
0.00%
Q4 2022$58,150
-54.2%
11,856
-39.9%
0.00%
Q3 2022$127,000
+4.1%
19,732
+3.0%
0.00%
Q2 2022$122,000
+248.6%
19,157
+281.9%
0.00%
Q1 2022$35,0000.0%5,016
+0.1%
0.00%
Q4 2021$35,000
-32.7%
5,012
-18.9%
0.00%
Q3 2021$52,000
+20.9%
6,1780.0%0.00%
Q2 2021$43,0000.0%6,178
-10.2%
0.00%
Q1 2021$43,000
+48.3%
6,878
+21.1%
0.00%
Q4 2020$29,000
+107.1%
5,678
+78.7%
0.00%
Q3 2020$14,000
-22.2%
3,1780.0%0.00%
Q2 2020$18,000
-60.9%
3,178
-58.1%
0.00%
Q1 2020$46,000
-28.1%
7,576
+7.6%
0.00%
Q4 2019$64,000
+8.5%
7,044
+9.6%
0.00%
Q3 2019$59,000
-16.9%
6,426
-8.2%
0.00%
Q2 2019$71,000
+7.6%
7,000
+48.4%
0.00%
Q1 2019$66,000
-54.5%
4,716
-48.3%
0.00%
Q4 2018$145,000
-54.7%
9,128
-46.4%
0.00%
Q3 2018$320,000
-56.3%
17,026
-55.3%
0.00%
Q2 2018$733,000
-19.5%
38,057
-10.7%
0.00%
Q1 2018$911,000
-14.7%
42,624
-17.9%
0.00%
Q4 2017$1,068,000
+11.2%
51,926
-0.3%
0.00%
Q3 2017$960,000
+14.7%
52,100
+55.4%
0.00%
Q2 2017$837,000
-43.7%
33,533
-54.7%
0.00%
Q1 2017$1,486,000
-46.8%
74,106
-34.5%
0.00%
Q4 2016$2,792,000
+384.7%
113,112
+289.3%
0.00%
Q3 2016$576,000
+1645.5%
29,053
+1098.1%
0.00%
Q2 2016$33,0000.0%2,4250.0%0.00%
Q1 2016$33,000
+6.5%
2,425
-21.1%
0.00%
Q4 2015$31,0000.0%3,0750.0%0.00%
Q3 2015$31,000
-85.0%
3,075
-78.0%
0.00%
Q2 2015$207,000
-82.6%
13,987
-80.5%
0.00%
Q1 2015$1,192,000
+36.1%
71,818
+24.2%
0.00%
Q4 2014$876,000
-2.4%
57,842
-8.8%
0.00%
Q3 2014$898,000
+2.2%
63,402
+2.2%
0.00%
Q2 2014$879,000
-27.5%
62,034
-12.3%
0.00%
-100.0%
Q1 2014$1,212,000
+11.8%
70,736
-4.1%
0.00%
Q4 2013$1,084,000
+34.3%
73,750
+21.1%
0.00%
Q3 2013$807,000
+46.7%
60,890
+18.9%
0.00%
Q2 2013$550,00051,1910.00%
Other shareholders
PSYCHEMEDICS CORP shareholders Q1 2022
NameSharesValueWeighting ↓
WEALTH EFFECTS LLC 44,501$218,2630.12%
Cannell Capital 74,794$366,8420.07%
SANTA MONICA PARTNERS LP 20,000$980.07%
RBF Capital, LLC 144,231$707,0000.05%
CRAWFORD INVESTMENT COUNSEL INC 257,795$1,264,4050.03%
Ancora Advisors LLC 70,916$3480.01%
WEDBUSH SECURITIES INC 30,928$1520.01%
Renaissance Technologies 290,463$1,4250.00%
GEODE CAPITAL MANAGEMENT, LLC 35,206$1730.00%
NORTHERN TRUST CORP 17,030$83,5270.00%
View complete list of PSYCHEMEDICS CORP shareholders